Ultramicrosize Griseofulvin Tablet, Coated
Product Images NDC 0781-5828

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ultramicrosize Griseofulvin (NDC 0781-5828). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure.jpg (Export 00)

Chemical structure of Ultramicrosize Griseofulvin, showing the arrangement of carbon, hydrogen, chlorine, and oxygen atoms. Molecular formula is C17H17ClO6, with a molecular weight of 352.77.*

FDA Label Image

125 mg Label (Image 01)

Ultramicrosize Griseofulvin Tablets, USP 125 mg coated tablets label for oral use. The label states the product is prescription only with a package count of 100 tablets. It is manufactured by USV Private Limited for Sandoz Inc and includes storage instructions and a barcode.*

FDA Label Image

250-mg (Image 02)

Label for Ultramicrosize Griseofulvin Tablets, USP 250 mg orally administered coated tablets. The label indicates a package size of 100 tablets and is marked Rx only. It includes storage instructions, manufacturer information (USV Private Limited for Sandoz Inc.), and a barcode. The label prominently features the Sandoz logo and contact details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.